Inhibitors of Cysteine Proteases and Methods of Use Thereof (2021)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 63/173,146, filed Apr 9, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,124,497 | Inhibitors of Cysteine Proteases and Methods of Use Thereof In force · High confidence | Pardes Biosciences, Inc. | In force | High confidence | ||
| US 11,312,704 | Inhibitors of Cysteine Proteases and Methods of Use Thereof In force · Medium confidence | Pardes Biosciences, Inc. | In force | Medium confidence | ||
| US 11,472,793 | Inhibitors of Cysteine Proteases and Methods of Use Thereof In force · Medium confidence | Pardes Biosciences, Inc. | In force | Medium confidence | ||
| Application 17/841,172 | Inhibitors of Cysteine Proteases and Methods of Use Thereof Abandoned Abandoned May 23, 2023 | Pardes Biosciences, Inc. | Abandoned | Abandoned May 23, 2023 | ||
| Application 17/859,827 | Inhibitors of Cysteine Proteases and Methods of Use Thereof Abandoned Abandoned Sep 11, 2023 | Pardes Biosciences, Inc. | Abandoned | Abandoned Sep 11, 2023 | ||
| Application 18/168,803 | Inhibitors of Cysteine Proteases and Methods of Use Thereof Pending Not granted | Pardes Biosciences, Inc. | Pending | Not granted | ||
| Application 18/461,179 | Inhibitors of Cysteine Proteases and Methods of Use Thereof Pending Not granted | Pardes Biosciences, Inc. | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Pardes Biosciences, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.